Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient
Phase 2
- Conditions
- Rheumatic Arthritis
- Registration Number
- NCT02020668
- Lead Sponsor
- Macmillan Research Group UK
- Brief Summary
Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.
Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
- Patients older than 18 years
- History of Rheumatoid Arthritis (RA) symptoms for less than 7 years
- Had RA by American College of Rheumatology (ACR) criteria
- ACR functional RA class I, II or III
- Hemoglobin more than 8g/dL without evidence of active bleeding
- Positive for rheumatoid factor (RF) or anti cyclic citrullinated protein
- standard conventional medicine were allowed within the approved dosage regimen
Exclusion Criteria
- connective tissue disease
- any other alternative or complementary medicine with in last 3 months.
- corticosteroid, disease modifying medicines
- Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases, carcinoma, drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Pain Change from baseline in Numerical Scale Downie at 16 weeks
- Secondary Outcome Measures
Name Time Method Quality of Life Change from Baseline in Short Form (SF) 36 at 16 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie physiotherapy's effects on rheumatoid arthritis inflammation and joint stiffness?
How does physiotherapy compare to standard-of-care DMARDs in reducing pain and improving quality of life for rheumatoid arthritis patients?
Are there specific biomarkers that predict response to physiotherapy interventions in rheumatic arthritis subtypes?
What are the potential adverse events associated with physiotherapy regimens in rheumatoid arthritis and how are they managed?
What combination therapies involving physiotherapy and biologic agents like TNF inhibitors show promise in rheumatoid arthritis management?
Trial Locations
- Locations (1)
Life Line Hospital
🇮🇳Sikar, Rajasthan, India
Life Line Hospital🇮🇳Sikar, Rajasthan, IndiaDeepika RatanContact9413623113